Jeffry Keyes Sells 37,382 Shares of Quantum-Si (NASDAQ:QSI) Stock

Quantum-Si Incorporated (NASDAQ:QSI) CFO Jeffry Keyes sold 37,382 shares of the business’s stock in a transaction on Monday, April 20th. The shares were sold at an average price of $1.01, for a total transaction of $37,755.82. Following the transaction, the chief financial officer directly owned 1,769,963 shares in the company, valued at approximately $1,787,662.63. The trade was a 2.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link.

Quantum-Si Trading Down 11.3%

Shares of Quantum-Si stock opened at $0.94 on Friday. The company’s fifty day simple moving average is $0.90 and its two-hundred day simple moving average is $1.27. The company has a market cap of $203.52 million, a P/E ratio of -1.81 and a beta of 3.08. Quantum-Si Incorporated has a 12-month low of $0.69 and a 12-month high of $3.10.

Quantum-Si (NASDAQ:QSI) last issued its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.06. The business had revenue of $0.45 million for the quarter, compared to the consensus estimate of $0.76 million. Quantum-Si had a negative net margin of 4,160.06% and a negative return on equity of 43.90%. Analysts predict that Quantum-Si Incorporated will post -0.5 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have issued reports on QSI. Canaccord Genuity Group reduced their price objective on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a research report on Wednesday, March 4th. Weiss Ratings reissued a “sell (d-)” rating on shares of Quantum-Si in a research report on Friday, March 27th. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Quantum-Si currently has an average rating of “Hold” and an average price target of $3.25.

Institutional Trading of Quantum-Si

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Vanguard Group Inc. grew its position in shares of Quantum-Si by 0.5% in the 3rd quarter. Vanguard Group Inc. now owns 8,714,507 shares of the company’s stock worth $12,287,000 after buying an additional 44,846 shares during the period. Geode Capital Management LLC grew its position in shares of Quantum-Si by 9.8% in the 4th quarter. Geode Capital Management LLC now owns 4,114,375 shares of the company’s stock worth $4,527,000 after buying an additional 367,206 shares during the period. Millennium Management LLC purchased a new stake in shares of Quantum-Si in the 1st quarter worth about $4,721,000. State Street Corp grew its position in shares of Quantum-Si by 26.5% in the 4th quarter. State Street Corp now owns 3,562,721 shares of the company’s stock worth $3,919,000 after buying an additional 745,231 shares during the period. Finally, Squarepoint Ops LLC purchased a new stake in shares of Quantum-Si in the 3rd quarter worth about $865,000. 39.90% of the stock is owned by hedge funds and other institutional investors.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.